{"id":"https://openalex.org/W2008286369","doi":"https://doi.org/10.2174/187152011794941172","title":"Protein Phosphatase 2A as a Potential Target for Anticancer Therapy","display_name":"Protein Phosphatase 2A as a Potential Target for Anticancer Therapy","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2008286369","doi":"https://doi.org/10.2174/187152011794941172","mag":"2008286369","pmid":"https://pubmed.ncbi.nlm.nih.gov/21288198"},"language":"en","primary_location":{"id":"doi:10.2174/187152011794941172","doi":"https://doi.org/10.2174/187152011794941172","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152011794941172","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2008286369"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073057863","display_name":"Peter Kalev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Kalev","raw_affiliation_strings":["Center for Human Genetics, KULeuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Human Genetics, KULeuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037059775","display_name":"Anna A. Sablina","orcid":"https://orcid.org/0000-0001-9526-4014","observed_orcids":["https://orcid.org/0000-0001-9526-4014"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna A. Sablina","raw_affiliation_strings":["CME Department, KULeuven, O I Herestraat 49, bus 602, Leuven, Belgium 3000.,Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CME Department, KULeuven, O I Herestraat 49, bus 602, Leuven, Belgium 3000.,Belgium","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I99464096"],"apc_list":null,"apc_paid":null,"fwci":3.0532,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.92738856,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"1","first_page":"38","last_page":"46"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.016699999570846558,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protein-phosphatase-2a","display_name":"protein phosphatase 2A","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6980000138282776},{"id":"https://openalex.org/keywords/serine-threonine-protein-phosphatase","display_name":"serine/threonine phosphatase","score":0.7889999747276306},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.8870000243186951},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.7139999866485596},{"id":"https://openalex.org/keywords/signaling-pathway-regulation","display_name":"signaling regulation","score":0.5860000252723694},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C389152","wikidata":"https://www.wikidata.org/wiki/Q6593007","display_name":"Protein phosphatase 2","level":4,"score":0.9254148006439209},{"id":"https://openalex.org/C178666793","wikidata":"https://www.wikidata.org/wiki/Q422476","display_name":"Phosphatase","level":3,"score":0.6999486684799194},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5575242042541504},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5310628414154053},{"id":"https://openalex.org/C2776414213","wikidata":"https://www.wikidata.org/wiki/Q183290","display_name":"Serine","level":3,"score":0.5304864048957825},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5272176265716553},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.5113713145256042},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5075627565383911},{"id":"https://openalex.org/C31734879","wikidata":"https://www.wikidata.org/wiki/Q14905494","display_name":"PTPN11","level":5,"score":0.4850596487522125},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.4535837769508362},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4517360329627991},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.42621710896492004},{"id":"https://openalex.org/C2775880066","wikidata":"https://www.wikidata.org/wiki/Q186521","display_name":"Threonine","level":4,"score":0.422495573759079},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4224418103694916},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.42210283875465393},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3438538908958435},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2659221589565277},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1023549735546112},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054648","descriptor_name":"Protein Phosphatase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D054648","descriptor_name":"Protein Phosphatase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/187152011794941172","doi":"https://doi.org/10.2174/187152011794941172","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152011794941172","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:21288198","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21288198","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer agents in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":91,"referenced_works":["https://openalex.org/W96068813","https://openalex.org/W165590492","https://openalex.org/W643643321","https://openalex.org/W1499540451","https://openalex.org/W1576014737","https://openalex.org/W1581414531","https://openalex.org/W1597583171","https://openalex.org/W1600787243","https://openalex.org/W1749352888","https://openalex.org/W1821169949","https://openalex.org/W1927723722","https://openalex.org/W1964540675","https://openalex.org/W1971212979","https://openalex.org/W1975748957","https://openalex.org/W1977536497","https://openalex.org/W1977599918","https://openalex.org/W1981076681","https://openalex.org/W1981083415","https://openalex.org/W1983269204","https://openalex.org/W1983475354","https://openalex.org/W1985911963","https://openalex.org/W1986492134","https://openalex.org/W1987528621","https://openalex.org/W1988862655","https://openalex.org/W1995022664","https://openalex.org/W1996655478","https://openalex.org/W1997664222","https://openalex.org/W1998911197","https://openalex.org/W2001194569","https://openalex.org/W2001600598","https://openalex.org/W2005939142","https://openalex.org/W2009706617","https://openalex.org/W2009884429","https://openalex.org/W2017653708","https://openalex.org/W2019257155","https://openalex.org/W2020195610","https://openalex.org/W2021029116","https://openalex.org/W2023692419","https://openalex.org/W2027338743","https://openalex.org/W2029180074","https://openalex.org/W2034269086","https://openalex.org/W2036109749","https://openalex.org/W2036495494","https://openalex.org/W2038638713","https://openalex.org/W2039775874","https://openalex.org/W2041171080","https://openalex.org/W2042145715","https://openalex.org/W2042377147","https://openalex.org/W2045002831","https://openalex.org/W2050571831","https://openalex.org/W2051485704","https://openalex.org/W2057836655","https://openalex.org/W2061243113","https://openalex.org/W2062181252","https://openalex.org/W2066013507","https://openalex.org/W2066893159","https://openalex.org/W2067761900","https://openalex.org/W2070544692","https://openalex.org/W2071733232","https://openalex.org/W2079828650","https://openalex.org/W2081958146","https://openalex.org/W2083459920","https://openalex.org/W2084352760","https://openalex.org/W2086389890","https://openalex.org/W2088377461","https://openalex.org/W2094659875","https://openalex.org/W2095152643","https://openalex.org/W2100411666","https://openalex.org/W2101038605","https://openalex.org/W2103252319","https://openalex.org/W2104214883","https://openalex.org/W2110054586","https://openalex.org/W2114081555","https://openalex.org/W2116932519","https://openalex.org/W2120720491","https://openalex.org/W2126361876","https://openalex.org/W2135425001","https://openalex.org/W2138869278","https://openalex.org/W2144611693","https://openalex.org/W2146597025","https://openalex.org/W2148155958","https://openalex.org/W2150268052","https://openalex.org/W2150988649","https://openalex.org/W2155205071","https://openalex.org/W2155286800","https://openalex.org/W2165408960","https://openalex.org/W2165704853","https://openalex.org/W2167522647","https://openalex.org/W2325151665","https://openalex.org/W2328214415","https://openalex.org/W4323284760"],"related_works":["https://openalex.org/W1987474302","https://openalex.org/W3177001660","https://openalex.org/W2045343723","https://openalex.org/W2884790554","https://openalex.org/W2533966492","https://openalex.org/W4390638072","https://openalex.org/W3011262690","https://openalex.org/W2889003443","https://openalex.org/W4387326295","https://openalex.org/W2559566458"],"abstract_inverted_index":{"The":[0,55],"kinase":[1,20],"oncogenes":[2],"are":[3],"well-characterized":[4],"drivers":[5],"of":[6,38,43,66,80,113],"cancer":[7,99],"development,":[8],"and":[9,17,70,96],"several":[10],"targeted":[11],"therapies":[12],"focused":[13],"on":[14],"both":[15,93],"specific":[16],"selectively":[18],"nonselective":[19],"inhibitors":[21],"have":[22,87],"now":[23],"been":[24,84],"approved":[25],"for":[26,50,110],"clinical":[27],"use.":[28],"In":[29],"contrast,":[30],"much":[31],"less":[32],"is":[33,61],"known":[34],"about":[35],"the":[36,48,64,111],"role":[37],"protein":[39,57],"phosphatases,":[40],"although":[41],"modulation":[42,79],"their":[44],"activities":[45],"might":[46],"form":[47],"foundation":[49],"an":[51],"effective":[52],"anti-cancer":[53],"approach.":[54],"serine-threonine":[56],"phosphatase":[58],"2A":[59],"(PP2A)":[60],"implicated":[62],"in":[63,92,94,97],"regulation":[65],"numerous":[67],"signaling":[68],"pathways":[69],"may":[71],"function":[72],"as":[73,105],"a":[74,88,106],"tumor":[75],"suppressor.":[76],"Recently":[77],"pharmacological":[78],"PP2A":[81,104],"activity":[82,91],"has":[83],"showed":[85],"to":[86],"potent":[89],"anti-tumor":[90],"vitro":[95],"vivo":[98],"models.":[100],"These":[101],"studies":[102],"implicate":[103],"promising":[107],"therapeutic":[108],"target":[109],"treatment":[112],"cancer.":[114]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2008286369","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
